Finland· FI-REL-REL1915
Emgesan
A magnesium hydroxide product containing magnesium hydroxide, registered in Finland by Viatris Oy. The same ATC class is registered in 3 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Magnesium hydroxide is registered in 3 of 19 countries.
Countries holding a registration under ATC G04BX01 (magnesium hydroxide), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Magnesium hydroxide · ATC G04BX01
3 / 19 countries
- Finlandprice
- Norwayprice
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Magnesium hydroxide
- Manufacturer
- Viatris Oy
- Country
- Finland (FI)
- ATC code
- G04BX01
- ATC class
- Magnesium hydroxide
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
444 interactions on record for magnesium hydroxide.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Magnesium hydroxide · interactions on record
444 records
- 8 severe
- 355 moderate
- 81 minor
Most severe, free to view
- Magnesium carbonateA02AA01moderate
- Magnesium oxideA02AA02moderate
- Aluminium glycinateA02AB07moderate
- MisoprostolA02BB01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Magnesium hydroxide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenEmgesan 250 mg TablettViatris AB
- United KingdomMagnesium oxide 250mg tabletsSpecial Order
- NorwayEmgesanMeda AS
- United StatesBestmade Natural Products Mag CarbBestmade Natural Products
- SwitzerlandAndreamag
- BelgiumCarbobel SimplexMedgenix Benelux
- Japanクエン酸マグネシウム堀井薬品工業
- GermanyBiolectra ForteHermes Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Biolectra, Dr. Böhm Direkt
- Belgium · Magmedi, Magneclo
- Bulgaria · Диаспорал Директ, Магнезиев Диаспорал
- Cyprus · Magnesia San Pellegrino
- Czechia · Magnesii Lactici Medicamenta, Magnesium Lactate Biomedica
- Germany · Biolectra Forte, Biolectra Forte Orangengeschmack
- Denmark · Diasporal, Magnesia
- Estonia · Magnesium Diasporal Protina Pharmazeutische Gesellschaft Mbh, Magnesium Diasporal Protina Pharmazeutische Gmbh
- Spain · Magnesia Cinfa, Magnesia Lainco
- France · Chlorumagene, Chlorure De Magnesium Lavoisier
- United Kingdom (Northern Ireland) · Magnaspartate, Magnesium Hydroxide Mixture Brown & Burk Uk
- Greece · Chymexan, Davimag
- Hungary · Antagel M, Magnesii Citrici Naturland
- Ireland · Magmedi, Magnence
- Iceland · Magnesia Dak
- Italy · Citrato Espresso Gabbiani, Magnesia
- Lithuania · Diasporal, Diasporal Direct
- Luxembourg · Emge, Mag 2
- Latvia · Diasporal, Magnesium Diasporal Direct Protina Pharmazeutische
- Malta · Magnesia
- Netherlands · Magmedi, Magnence
- Norway · Nycoplus
- Poland · Magnezin, Slow-Mag
- Portugal · Leite De Magnésia Phillips, Magnoral
- Sweden · Magnesium Eql Pharma, Magnesium Evolan
- Slovenia · Magnesium Protina, Magnesol
- Slovakia · Magnesii Lactas Galvex, Magnesii Lactas Vulm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ec6655f0-cfcc-4c2a-94b3-d40df4e3bb1a GET /v1/drugs/ec6655f0-cfcc-4c2a-94b3-d40df4e3bb1a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.5",
"form": "tabletti",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "250 mg",
"atc_label": "magnesiumhydroksidi",
"ma_number": "9140",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL1915",
"authorised_at": "1985-10-30"
}See everything about magnesium hydroxide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.